Impella RP in hemodynamically unstable patients with acute pulmonary embolism
Over the last years, different case reports/studies have demonstrated that in patients with acute pulmonary embolism (PE) and refractory shock mechanical circulatory support (MCS) with Impella RP ® (Abiomed, Inc, Danvers, Mass) increases the chances of survival, significantly unloading the right ven...
Gespeichert in:
Veröffentlicht in: | Journal of artificial organs 2020-06, Vol.23 (2), p.105-112 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 112 |
---|---|
container_issue | 2 |
container_start_page | 105 |
container_title | Journal of artificial organs |
container_volume | 23 |
creator | Zuin, Marco Rigatelli, Gianluca Daggubati, Ramesh Nguyen, Thach Roncon, Loris |
description | Over the last years, different case reports/studies have demonstrated that in patients with acute pulmonary embolism (PE) and refractory shock mechanical circulatory support (MCS) with Impella RP
®
(Abiomed, Inc, Danvers, Mass) increases the chances of survival, significantly unloading the right ventricle and improving both the cardiac output and the mean pulmonary artery pressure. We reviewed the medical literature about the use of Impella RP in patients with acute PE and refractory shock using PubMed (MEDLINE), Scopus, Cochrane library, and Google Scholar databases. The final research was conducted in July 2019. The results evidenced that available data are currently scant to definitively assess the real role Impella RP
®
in patient with acute PE and refractory shock. However, preliminary data seems to be very promising. Further larger studies are needed to confirm the safety and efficacy of MCS in these patients. A multidisciplinary assessment, using the PERT team, must be performed case by case to determine the need of MCS. |
doi_str_mv | 10.1007/s10047-019-01149-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2330326825</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2330326825</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-895aad0aae0bbf7bddbd3d2255a433a411a9cef0012b5e56b27ea28e59b568353</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwAyxQJDZsAn7G8RJVvKQiEIK1ZScOTWU7JU6E-vc4TQGJBQu_Zs5cz1wAThG8RBDyqxB3ylOIRFyIilTsgSnKhqeAdD_eKaEpx1hMwFEIKwgRZxwegglBOSc55lPw-ODWxlqVvDwntU-WxjXlxitXF8raTdL70CltTbJWXW18F5LPulsmqui7GOuta7xqN4lxurF1cMfgoFI2mJPdOQNvtzev8_t08XT3ML9epAUlWZfmgilVQqUM1Lriuix1SUqMGVOUEEURUqIwVewXa2ZYpjE3CueGCc2ynDAyAxej7rptPnoTOunqUAxzeNP0QWJCIMFZjgf0_A-6avrWx-4kppAQxPCWwiNVtE0Irankuq1dHE0iKAez5Wi2jGbLrdlSxKKznXSvnSl_Sr7djQAZgRBT_t20v3__I_sFhDqKNg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2403315225</pqid></control><display><type>article</type><title>Impella RP in hemodynamically unstable patients with acute pulmonary embolism</title><source>SpringerLink Journals - AutoHoldings</source><creator>Zuin, Marco ; Rigatelli, Gianluca ; Daggubati, Ramesh ; Nguyen, Thach ; Roncon, Loris</creator><creatorcontrib>Zuin, Marco ; Rigatelli, Gianluca ; Daggubati, Ramesh ; Nguyen, Thach ; Roncon, Loris</creatorcontrib><description>Over the last years, different case reports/studies have demonstrated that in patients with acute pulmonary embolism (PE) and refractory shock mechanical circulatory support (MCS) with Impella RP
®
(Abiomed, Inc, Danvers, Mass) increases the chances of survival, significantly unloading the right ventricle and improving both the cardiac output and the mean pulmonary artery pressure. We reviewed the medical literature about the use of Impella RP in patients with acute PE and refractory shock using PubMed (MEDLINE), Scopus, Cochrane library, and Google Scholar databases. The final research was conducted in July 2019. The results evidenced that available data are currently scant to definitively assess the real role Impella RP
®
in patient with acute PE and refractory shock. However, preliminary data seems to be very promising. Further larger studies are needed to confirm the safety and efficacy of MCS in these patients. A multidisciplinary assessment, using the PERT team, must be performed case by case to determine the need of MCS.</description><identifier>ISSN: 1434-7229</identifier><identifier>EISSN: 1619-0904</identifier><identifier>DOI: 10.1007/s10047-019-01149-9</identifier><identifier>PMID: 31873827</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Biomedical Engineering and Bioengineering ; Cardiac output ; Cardiac Surgery ; Case reports ; Embolism ; Embolisms ; Health risk assessment ; Mechanical unloading ; Medicine ; Medicine & Public Health ; Nephrology ; PERT ; Pulmonary arteries ; Pulmonary artery ; Pulmonary embolisms ; Review ; Ventricle</subject><ispartof>Journal of artificial organs, 2020-06, Vol.23 (2), p.105-112</ispartof><rights>The Japanese Society for Artificial Organs 2019</rights><rights>The Japanese Society for Artificial Organs 2019.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-895aad0aae0bbf7bddbd3d2255a433a411a9cef0012b5e56b27ea28e59b568353</citedby><cites>FETCH-LOGICAL-c436t-895aad0aae0bbf7bddbd3d2255a433a411a9cef0012b5e56b27ea28e59b568353</cites><orcidid>0000-0001-9164-9160</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10047-019-01149-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10047-019-01149-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31873827$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zuin, Marco</creatorcontrib><creatorcontrib>Rigatelli, Gianluca</creatorcontrib><creatorcontrib>Daggubati, Ramesh</creatorcontrib><creatorcontrib>Nguyen, Thach</creatorcontrib><creatorcontrib>Roncon, Loris</creatorcontrib><title>Impella RP in hemodynamically unstable patients with acute pulmonary embolism</title><title>Journal of artificial organs</title><addtitle>J Artif Organs</addtitle><addtitle>J Artif Organs</addtitle><description>Over the last years, different case reports/studies have demonstrated that in patients with acute pulmonary embolism (PE) and refractory shock mechanical circulatory support (MCS) with Impella RP
®
(Abiomed, Inc, Danvers, Mass) increases the chances of survival, significantly unloading the right ventricle and improving both the cardiac output and the mean pulmonary artery pressure. We reviewed the medical literature about the use of Impella RP in patients with acute PE and refractory shock using PubMed (MEDLINE), Scopus, Cochrane library, and Google Scholar databases. The final research was conducted in July 2019. The results evidenced that available data are currently scant to definitively assess the real role Impella RP
®
in patient with acute PE and refractory shock. However, preliminary data seems to be very promising. Further larger studies are needed to confirm the safety and efficacy of MCS in these patients. A multidisciplinary assessment, using the PERT team, must be performed case by case to determine the need of MCS.</description><subject>Biomedical Engineering and Bioengineering</subject><subject>Cardiac output</subject><subject>Cardiac Surgery</subject><subject>Case reports</subject><subject>Embolism</subject><subject>Embolisms</subject><subject>Health risk assessment</subject><subject>Mechanical unloading</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nephrology</subject><subject>PERT</subject><subject>Pulmonary arteries</subject><subject>Pulmonary artery</subject><subject>Pulmonary embolisms</subject><subject>Review</subject><subject>Ventricle</subject><issn>1434-7229</issn><issn>1619-0904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EoqXwAyxQJDZsAn7G8RJVvKQiEIK1ZScOTWU7JU6E-vc4TQGJBQu_Zs5cz1wAThG8RBDyqxB3ylOIRFyIilTsgSnKhqeAdD_eKaEpx1hMwFEIKwgRZxwegglBOSc55lPw-ODWxlqVvDwntU-WxjXlxitXF8raTdL70CltTbJWXW18F5LPulsmqui7GOuta7xqN4lxurF1cMfgoFI2mJPdOQNvtzev8_t08XT3ML9epAUlWZfmgilVQqUM1Lriuix1SUqMGVOUEEURUqIwVewXa2ZYpjE3CueGCc2ynDAyAxej7rptPnoTOunqUAxzeNP0QWJCIMFZjgf0_A-6avrWx-4kppAQxPCWwiNVtE0Irankuq1dHE0iKAez5Wi2jGbLrdlSxKKznXSvnSl_Sr7djQAZgRBT_t20v3__I_sFhDqKNg</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>Zuin, Marco</creator><creator>Rigatelli, Gianluca</creator><creator>Daggubati, Ramesh</creator><creator>Nguyen, Thach</creator><creator>Roncon, Loris</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9164-9160</orcidid></search><sort><creationdate>20200601</creationdate><title>Impella RP in hemodynamically unstable patients with acute pulmonary embolism</title><author>Zuin, Marco ; Rigatelli, Gianluca ; Daggubati, Ramesh ; Nguyen, Thach ; Roncon, Loris</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-895aad0aae0bbf7bddbd3d2255a433a411a9cef0012b5e56b27ea28e59b568353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biomedical Engineering and Bioengineering</topic><topic>Cardiac output</topic><topic>Cardiac Surgery</topic><topic>Case reports</topic><topic>Embolism</topic><topic>Embolisms</topic><topic>Health risk assessment</topic><topic>Mechanical unloading</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nephrology</topic><topic>PERT</topic><topic>Pulmonary arteries</topic><topic>Pulmonary artery</topic><topic>Pulmonary embolisms</topic><topic>Review</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zuin, Marco</creatorcontrib><creatorcontrib>Rigatelli, Gianluca</creatorcontrib><creatorcontrib>Daggubati, Ramesh</creatorcontrib><creatorcontrib>Nguyen, Thach</creatorcontrib><creatorcontrib>Roncon, Loris</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of artificial organs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zuin, Marco</au><au>Rigatelli, Gianluca</au><au>Daggubati, Ramesh</au><au>Nguyen, Thach</au><au>Roncon, Loris</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impella RP in hemodynamically unstable patients with acute pulmonary embolism</atitle><jtitle>Journal of artificial organs</jtitle><stitle>J Artif Organs</stitle><addtitle>J Artif Organs</addtitle><date>2020-06-01</date><risdate>2020</risdate><volume>23</volume><issue>2</issue><spage>105</spage><epage>112</epage><pages>105-112</pages><issn>1434-7229</issn><eissn>1619-0904</eissn><abstract>Over the last years, different case reports/studies have demonstrated that in patients with acute pulmonary embolism (PE) and refractory shock mechanical circulatory support (MCS) with Impella RP
®
(Abiomed, Inc, Danvers, Mass) increases the chances of survival, significantly unloading the right ventricle and improving both the cardiac output and the mean pulmonary artery pressure. We reviewed the medical literature about the use of Impella RP in patients with acute PE and refractory shock using PubMed (MEDLINE), Scopus, Cochrane library, and Google Scholar databases. The final research was conducted in July 2019. The results evidenced that available data are currently scant to definitively assess the real role Impella RP
®
in patient with acute PE and refractory shock. However, preliminary data seems to be very promising. Further larger studies are needed to confirm the safety and efficacy of MCS in these patients. A multidisciplinary assessment, using the PERT team, must be performed case by case to determine the need of MCS.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>31873827</pmid><doi>10.1007/s10047-019-01149-9</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-9164-9160</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1434-7229 |
ispartof | Journal of artificial organs, 2020-06, Vol.23 (2), p.105-112 |
issn | 1434-7229 1619-0904 |
language | eng |
recordid | cdi_proquest_miscellaneous_2330326825 |
source | SpringerLink Journals - AutoHoldings |
subjects | Biomedical Engineering and Bioengineering Cardiac output Cardiac Surgery Case reports Embolism Embolisms Health risk assessment Mechanical unloading Medicine Medicine & Public Health Nephrology PERT Pulmonary arteries Pulmonary artery Pulmonary embolisms Review Ventricle |
title | Impella RP in hemodynamically unstable patients with acute pulmonary embolism |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T12%3A26%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impella%20RP%20in%20hemodynamically%20unstable%20patients%20with%20acute%20pulmonary%20embolism&rft.jtitle=Journal%20of%20artificial%20organs&rft.au=Zuin,%20Marco&rft.date=2020-06-01&rft.volume=23&rft.issue=2&rft.spage=105&rft.epage=112&rft.pages=105-112&rft.issn=1434-7229&rft.eissn=1619-0904&rft_id=info:doi/10.1007/s10047-019-01149-9&rft_dat=%3Cproquest_cross%3E2330326825%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2403315225&rft_id=info:pmid/31873827&rfr_iscdi=true |